ALEC ▲ +21.0% - Alector, Inc.
$ALEC - Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
05-OCT-2026 07:00 AM ET
Share this post
More filings for $ALEC
ALEC - Alector, Inc. - SEC Filing Update (18-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 18, 2026ALEC ▼ -7.7% - Alector, Inc.Sep 3, 2026
View full $ALEC filing history →💬 Comments
Loading comments…
Leave a comment